X4 Pharmaceuticals Stock Quote XFOR - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.6786

Bid

0.6803

Ask

0.74

Volume

692,613

0.695 Day's Range 0.727

0.5311 52 Week Range 1.60

Market Cap

114.344M

Previous Close

0.7032

Open

0.7099

Last Trade

0.7254

Last Trade Time

16:46:38

Financial Volume

$ 493,945

VWAP

0.713162

Average Volume (3m)

1,917,604

Shares Outstanding

168,499,514

Dividend Yield

PE Ratio

-1.18

Earnings Per Share (EPS)

-0.6

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was $0.70. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of $ 0.5311 to $ 1.60.

X4 Pharmaceuticals currently has 168,499,514 shares outstanding. The market capitalization of X4 Pharmaceuticals is $118.49 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.18.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0097	-1.40926921401	0.6883	0.7399	0.635	700889	0.68975521	CS
4	-0.0962	-12.4161073826	0.7748	0.785	0.61	688628	0.6957163	CS
12	-0.2076	-23.4258632363	0.8862	0.8986	0.5311	1917604	0.66589556	CS
26	-0.2399	-26.1186717474	0.9185	1.6	0.5311	2528825	1.0074073	CS
52	-0.4214	-38.3090909091	1.1	1.6	0.5311	2183215	0.92924811	CS
156	-4.4614	-86.7976653696	5.14	6.18	0.5311	1579279	1.31675289	CS
260	-13.3714	-95.1701067616	14.05	15.75	0.5311	980218	1.61738184	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LFLYLeafly Holdings Inc	$ 3.95 (120.67%)	4.06M
TNONTenon Medical Inc	$ 7.11 (41.35%)	2.04M
AENTAlliance Entertainment Holding Corporation	$ 2.85 (39.71%)	99.65k
AEMDAethlon Medical Inc	$ 0.493 (26.41%)	7.69M
GSIWGarden Stage Ltd	$ 9.26 (18.26%)	2.8M
EJHE Home Household Service Holdings Ltd	$ 0.074 (-24.18%)	6.63M
KOPNKopin Corporation	$ 0.80 (-17.02%)	154.63k
NCINeo Concept International Group Holdings Ltd	$ 0.703401 (-16.26%)	1.43M
IPWiPower Inc	$ 1.47 (-9.26%)	68.21k
WBUYWeBuy Global Ltd	$ 0.1455 (-8.38%)	120.46k
AEMDAethlon Medical Inc	$ 0.493 (26.41%)	7.69M
EJHE Home Household Service Holdings Ltd	$ 0.074 (-24.18%)	6.63M
HSTHost Hotels and Resorts Inc	$ 18.53 (0.00%)	6.45M
LFLYLeafly Holdings Inc	$ 3.95 (120.67%)	4.06M
NVDANVIDIA Corporation	$ 117.84 (-0.03%)	3.86M